Jessica Molkentine
6PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance.Venu Thatikonda, Hengyu Lyu, Sabine Jurado
|Apr 27, 2024
Th2 Cells Are Associated with Tumor Recurrence Following Radiation.Mohamed K Abdelhakiem, Riyue Bao, Phillip M Pifer
|Oct 11, 2023
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.Phillip M Pifer, Liangpeng Yang, Manish Kumar
|Dec 30, 2021
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.David P Molkentine, Jessica M Molkentine, Kathleen A Bridges
|Nov 04, 2021
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.Manish Kumar, David Molkentine, Jessica Molkentine
|Feb 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.Jessica M Molkentine, David P Molkentine, Kathleen A Bridges
Pageof 1
Frequent Collaborators
4 joint publications
Mohamed K Abdelhakiem
3 joint publications
Heath D Skinner
3 joint publications
David P Molkentine
3 joint publications
Annika Dhawan
3 joint publications
Liangpeng Yang
3 joint publications
Curtis R Pickering
2 joint publications
Manish Kumar
2 joint publications
Phillip M Pifer
2 joint publications
Beth M Beadle
2 joint publications
Timothy P Heffernan
